Ohara Y - Search Results

1

SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer.

Ohara Y, Tang W, Liu H, Yang S, Dorsey TH, Cawley H, Moreno P, Chari R, Guest MR, Azizian A, Gaedcke J, Ghadimi M, Hanna N, Ambs S, Hussain SP. Ohara Y, et al. Cell Rep. 2023 Dec 26;42(12):113434. doi: 10.1016/j.celrep.2023.113434. Epub 2023 Nov 18. Cell Rep. 2023. PMID: 37980563 Free PMC article.

2

Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients.

Yang S, Tang W, Azizian A, Gaedcke J, Ströbel P, Wang L, Cawley H, Ohara Y, Valenzuela P, Zhang L, Lal T, Sinha S, Rupin E, Hanna N, Ghadimi BM, Hussain SP. Yang S, et al. Among authors: ohara y. Carcinogenesis. 2022 Dec 31;43(12):1198-1210. doi: 10.1093/carcin/bgac092. Carcinogenesis. 2022. PMID: 36426859 Free PMC article.

3

Diabetes-associated breast cancer is molecularly distinct and shows a DNA damage repair deficiency.

Panigrahi G, Candia J, Dorsey TH, Tang W, Ohara Y, Byun JS, Minas TZ, Zhang A, Ajao A, Cellini A, Yfantis HG, Flis AL, Mann D, Ioffe O, Wang XW, Liu H, Loffredo CA, Napoles AM, Ambs S. Panigrahi G, et al. Among authors: ohara y. JCI Insight. 2023 Dec 8;8(23):e170105. doi: 10.1172/jci.insight.170105. JCI Insight. 2023. PMID: 37906280 Free PMC article.

4

LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism.

Ohara Y, Craig AJ, Liu H, Yang S, Moreno P, Dorsey TH, Cawley H, Azizian A, Gaedcke J, Ghadimi M, Hanna N, Ambs S, Hussain SP. Ohara Y, et al. Carcinogenesis. 2024 Jul 8;45(7):475-486. doi: 10.1093/carcin/bgae011. Carcinogenesis. 2024. PMID: 38366633

5

MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK-ERK and AP-1 pathways.

Yang S, Tang W, Azizian A, Gaedcke J, Ohara Y, Cawley H, Hanna N, Ghadimi M, Lal T, Sen S, Creighton CJ, Gao J, Putluri N, Ambs S, Hussain P. Yang S, et al. Among authors: ohara y. Carcinogenesis. 2024 Aug 12;45(8):582-594. doi: 10.1093/carcin/bgae025. Carcinogenesis. 2024. PMID: 38629149

6

ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer.

Ohara Y, Liu H, Craig AJ, Yang S, Moreno P, Dorsey TH, Cawley H, Azizian A, Gaedcke J, Ghadimi M, Hanna N, Ambs S, Hussain SP. Ohara Y, et al. Int J Cancer. 2024 Aug 1;155(3):569-581. doi: 10.1002/ijc.34960. Epub 2024 Apr 17. Int J Cancer. 2024. PMID: 38630934

7

ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer.

Moreno P, Ohara Y, Craig AJ, Liu H, Yang S, Zhang L, Panigrahi G, Dorsey TH, Cawley H, Azizian A, Gaedcke J, Ghadimi M, Hanna N, Perwez Hussain S. Moreno P, et al. Among authors: ohara y. bioRxiv [Preprint]. 2024 Mar 13:2024.03.12.584316. doi: 10.1101/2024.03.12.584316. bioRxiv. 2024. Update in: Carcinogenesis. 2024 Nov 22;45(11):845-856. doi: 10.1093/carcin/bgae056 PMID: 38903083 Free PMC article. Updated. Preprint.

8

ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer.

Moreno P, Ohara Y, Craig AJ, Liu H, Yang S, Dorsey TH, Zhang L, Panigrahi G, Cawley H, Azizian A, Gaedcke J, Ghadimi M, Hanna N, Hussain SP. Moreno P, et al. Among authors: ohara y. Carcinogenesis. 2024 Nov 22;45(11):845-856. doi: 10.1093/carcin/bgae056. Carcinogenesis. 2024. PMID: 39136088

9

A case of nevoid basal cell carcinoma syndrome with segmentally unilaterally arranged hypertrichosis and circumscribed palmar hypokeratosis histologically presenting as basal cell carcinoma.

Maeda C, Kido I, Ohara Y, Kase M, Nakajima H, Nakajima K, Nakai K. Maeda C, et al. Among authors: ohara y. J Dermatol. 2024 Dec 15. doi: 10.1111/1346-8138.17593. Online ahead of print. J Dermatol. 2024. PMID: 39676454 No abstract available.

10

Graft CD8⁺ T cells for improving event-free survival after T cell-replete haploidentical stem cell transplantation in children with hematological malignancies.

Takahashi N, Mochizuki K, Kikuta A, Ohara Y, Kudo S, Ikeda K, Ohto H, Sano H. Takahashi N, et al. Among authors: ohara y. Int J Hematol. 2024 Dec 10. doi: 10.1007/s12185-024-03900-2. Online ahead of print. Int J Hematol. 2024. PMID: 39656374

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

638 results

Search Page

Filters